Synthaverse S.A.

Synthaverse S.A.verified

SVE.WA

Price:

$3.87

Market Cap:

$272.44M

Synthaverse S.A., a pharmaceutical company, manufactures and sells medicinal products, medical devices, and laboratory reagents in Poland. The company's prescription drugs include Distreptaza, a medication used in gynecology for treating chronic inflammatory disease of the uterine appendages and hemorrhoids; Onko BCG 50 and BCG 100 products for treating superficial (non-muscle invasive) bladder tumor; GAMMA anty HBs 200 medications for passive immunization against hepatitis B; GAMMA anty-D 50 and GAMMA anty-D 150, which are Anti D (Rho) immunoglobulin products used in prevention of hemolytic disease of the foetus and newborn; BioTrombina 400, a medication for topical control of severe bleedi...[Read more]

Industry

Biotechnology

IPO Date

2011-07-29

Stock Exchange

WSE

Ticker

SVE.WA

The Enterprise Value as of December 2025 (TTM) for Synthaverse S.A. (SVE.WA) is 348.28M

According to Synthaverse S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 348.28M. This represents a change of -14.15% compared to the average of 405.66M of the last 4 quarters.

Synthaverse S.A. (SVE.WA) Historical Enterprise Value (quarterly & annually)

How has SVE.WA Enterprise Value performed in the past?

The mean historical Enterprise Value of Synthaverse S.A. over the last ten years is 248.12M. The current 348.28M Enterprise Value has changed 13.94% with respect to the historical average. Over the past ten years (40 quarters), SVE.WA's Enterprise Value was at its highest in in the September 2020 quarter at 1.06B. The Enterprise Value was at its lowest in in the June 2021 quarter at 0.

Quarterly (TTM)
Annual

Average

248.12M

Median

203.27M

Minimum

74.29M

Maximum

569.31M

Synthaverse S.A. (SVE.WA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Synthaverse S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 666.35%

Maximum Annual Enterprise Value = 569.31M

Minimum Annual Increase = -52.14%

Minimum Annual Enterprise Value = 74.29M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024398.38M8.29%
2023367.88M-3.20%
2022380.03M39.48%
2021272.46M-52.14%
2020569.31M666.35%
201974.29M-2.53%
201876.22M-20.17%
201795.47M-15.58%
2016113.08M-15.66%
2015134.08M12.68%

Synthaverse S.A. (SVE.WA) Average Enterprise Value

How has SVE.WA Enterprise Value performed in the past?

The current Enterprise Value of Synthaverse S.A. (SVE.WA) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

382.10M

5-year avg

397.61M

10-year avg

248.12M

Synthaverse S.A. (SVE.WA) Enterprise Value vs. Peers

How is SVE.WA’s Enterprise Value compared to its peers?

Synthaverse S.A.’s Enterprise Value is less than Bioton S.a. (387.75M), less than Captor Therapeutics Spolka Akcyjna (365.50M), greater than Molecure S.A. (116.44M), greater than Medicalgorithmics S.A. (348.27M), greater than Mabion S.A. (109.33M), greater than Poltreg S.A. (88.22M), less than Bioceltix S.A. (395.52M), greater than Pharmena S.A. (34.30M), greater than Mercator Medical S.A. (230.26M), greater than NanoGroup S.A. (89.30M),

CompanyEnterprise ValueMarket cap
387.75M$343.46M
365.50M$379.25M
116.44M$150.40M
348.27M$345.86M
109.33M$129.46M
88.22M$111.46M
395.52M$427.43M
34.30M$34.30M
230.26M$351.62M
89.30M$90.22M

Build a custom stock screener for Synthaverse S.A. (SVE.WA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Synthaverse S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Synthaverse S.A. (SVE.WA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Synthaverse S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Synthaverse S.A.'s Enterprise Value?

What is the highest Enterprise Value for Synthaverse S.A. (SVE.WA)?

What is the 3-year average Enterprise Value for Synthaverse S.A. (SVE.WA)?

What is the 5-year average Enterprise Value for Synthaverse S.A. (SVE.WA)?

How does the current Enterprise Value for Synthaverse S.A. (SVE.WA) compare to its historical average?